Heterogeneity of mesenchymal stem cells (MSCs) influences the cell therapy outcome and the application in tissue engineering. Also, the application of subpopulations of MSCs in cartilage regeneration remains poorly characterized. CD146+ MSCs are identified as the natural ancestors of MSCs and the expression of CD146 are indicative of greater pluripotency and self-renewal potential. Here, we sorted a CD146 subpopulation from adipose-derived mesenchymal stem cells (ADSCs) for cartilage regeneration. : CD146 ADSCs were sorted using magnetic activated cell sorting (MACS). Cell surface markers, viability, apoptosis and proliferation were evaluated . The molecular signatures were analyzed by mRNA and protein expression profiling. By intra-articular injections of cells in a rat osteochondral defect model, we assessed the role of the specific subpopulation in cartilage microenvironment. Finally, CD146 ADSCs were combined with articular cartilage extracellular matrix (ACECM) scaffold for long term (3, 6 months) cartilage repair. : The enriched CD146 ADSCs showed a high expression of stem cell and pericyte markers, good viability, and immune characteristics to avoid allogeneic rejection. Gene and protein expression profiles revealed that the CD146 ADSCs had different cellular functions especially in regulation inflammation. In a rat model, CD146 ADSCs showed a better inflammation-modulating property in the early stage of intra-articular injections. Importantly, CD146 ADSCs exhibited good biocompatibility with the ACECM scaffold and the CD146 cell-scaffold composites produced less subcutaneous inflammation. The combination of CD146 ADSCs with ACECM scaffold can promote better cartilage regeneration in the long term. : Our data elucidated the function of the CD146 ADSC subpopulation, established their role in promoting cartilage repair, and highlighted the significance of cell subpopulations as a novel therapeutic for cartilage regeneration.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691381 | PMC |
http://dx.doi.org/10.7150/thno.33904 | DOI Listing |
J Orthop Surg Res
December 2023
Department of Orthopedics, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Pudong, Shanghai, 201399, China.
Background: The use of adipose stem cell (ADSCs) subpopulations in cartilage repair remains poorly characterized. In this study, we constructed an albumin magnetic sphere with specific targeting of CD146 (CD146-AMs) for sorting a subpopulation of CD146-positive ADSCs (CD146 + ADSCs) and explored the role of CD146 + ADSCs on joint pain and cartilage repair in rats with knee osteoarthritis (KOA).
Methods: CD146-AMs were prepared and analyzed in materialistic characterization tests.
J Clin Periodontol
December 2022
Yunnan Key Laboratory of Stomatology, Kunming Medical University, Kunming, Yunnan, PR China.
Aim: To compare the efficacy of adipocyte-derived dedifferentiated fat (DFAT) cell and adipose-derived stromal cell (ADSC) sheets for regenerative treatment of intra-bony periodontal defects.
Materials And Methods: DFAT cells were obtained using the ceiling culture method and were compared with ADSCs using Cell Counting Kit-8, colony formation assay, surface antigen identification, and multilineage differentiation assays. DFAT and ADSC sheets were prepared in a cell sheet culture medium.
World J Stem Cells
September 2021
Department of Orthopaedic Surgery, University of Virginia School of Medicine, Charlottesville, VA 22908, United States.
Injuries to the postnatal skeleton are naturally repaired through successive steps involving specific cell types in a process collectively termed "bone regeneration". Although complex, bone regeneration occurs through a series of well-orchestrated stages wherein endogenous bone stem cells play a central role. In most situations, bone regeneration is successful; however, there are instances when it fails and creates non-healing injuries or fracture nonunion requiring surgical or therapeutic interventions.
View Article and Find Full Text PDFStem Cells Int
April 2021
Department of Urology, University of Tübingen Hospital, Tübingen, Germany.
Mesenchymal stromal cells (MSCs) have been successfully employed in clinical applications. In most studies, autologous MSCs from the bone marrow (bmMSCs) were used, and others employed autologous adipose tissue-derived stromal cells (ADSCs). Recently, clinical feasibility studies provided evidence that MSCs from human term placenta (pMSCs) can be used for homologous therapy facilitating access to regenerative cells in emergency situations, when autologous cells are not available or not suitable.
View Article and Find Full Text PDFJ Cell Mol Med
May 2021
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
This study aimed to investigate the ability of CD146 subset of ADSCs to repair cartilage defects. In this study, we prepared CD146 liposome magnetic beads (CD146 LMB) to isolate CD146 ADSCs. The cells were induced for chondrogenic differentiation and verified by cartilage-specific mRNA and protein expression.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!